Skip to main content
. 2021 Feb 1;9:19. doi: 10.1186/s40478-021-01119-4

Fig. 4.

Fig. 4

Nlgn1 reduction in frontal grey matter of tauopathies. Nlgn1 levels analysed in a tauopathies cohort including AD (n = 10), PiD (n = 9), CBD (n = 10), PSP (n = 11) and Ctrl (n = 10) from frontal grey matter. a representative Western blot and relative GAPDH signal. Samples were run as singlicates. A calibration curve of recombinant Nlgn1 fusion protein was used to estimate the amount of Nlgn1 present in the samples (as above). b The bars presented in the scatterplots show the median and the interquartile range. Significance: p ≤ 0.05